Issue navigation
Volume 24, Issue Supplement_I, November 2022
CCC 2022 - State of the Art Cardiology
CCC 2022 - State of the Art Cardiology Supplement Papers
Surgical approach to combined mitral and tricuspid valve disease: good neighbourhood rules
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I1–I8, https://doi.org/10.1093/eurheartjsupp/suac096
Genetics and clinics: together to diagnose cardiomyopathies
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I9–I15, https://doi.org/10.1093/eurheartjsupp/suac097
Transcatheter mitral valve replacement: there is still work to be done
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I16–I21, https://doi.org/10.1093/eurheartjsupp/suac098
An aggressive solution for patients with heart failure and atrial fibrillation: nodal ablation and cardiac resynchronization therapy
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I22–I24, https://doi.org/10.1093/eurheartjsupp/suac068
Computed tomography to replace invasive coronary angiography? The DISCHARGE trial
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I25–I28, https://doi.org/10.1093/eurheartjsupp/suac067
‘Use of lipid-lowering therapy: the guidelines, the drugs or the patient?’
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I29–I33, https://doi.org/10.1093/eurheartjsupp/suac069
Reduction of cerebrovascular and peripheral events with PCSK9 inhibitors: Does it just depend on the lowering of the low-density lipoprotein?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I34–I37, https://doi.org/10.1093/eurheartjsupp/suac099
Echocardiography strain: why is it used more and more?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I38–I42, https://doi.org/10.1093/eurheartjsupp/suac070
Therapeutic uncertainties: first finding of atrial fibrillation in acute coronary syndrome
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I43–I46, https://doi.org/10.1093/eurheartjsupp/suac072
The many NOs to the use of Class IC antiarrhythmics: weren’t the guidelines too strict?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I47–I53, https://doi.org/10.1093/eurheartjsupp/suac073
The stent in the high-bleeding risk patient: antiplatelet monotherapy?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I54–I56, https://doi.org/10.1093/eurheartjsupp/suac074
Some good reasons to proceed with the occlusion of the auricle
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I57–I60, https://doi.org/10.1093/eurheartjsupp/suac100
The myocardial bridge: incidence, diagnosis, and prognosis of a pathology of uncertain clinical significance
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I61–I67, https://doi.org/10.1093/eurheartjsupp/suac075
Sodium–glucose co-transporter 2 inhibitors for the treatment of cardio-renal syndrome
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I68–I71, https://doi.org/10.1093/eurheartjsupp/suac101
Role of lipoprotein(a) in plaque progression
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I72–I75, https://doi.org/10.1093/eurheartjsupp/suac071
Pollution and coronary risk: how much does it matter?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I76–I80, https://doi.org/10.1093/eurheartjsupp/suac076
The percutaneous coronary angioplasty gets better, but the surgical coronary artery bypass does not stay behind
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I81–I83, https://doi.org/10.1093/eurheartjsupp/suac077
The link between influenza and myocardial infarction: vaccination protects
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I84–I88, https://doi.org/10.1093/eurheartjsupp/suac078
Ischaemic stroke in the absence of documented atrial fibrillation: is there who could benefit from anticoagulant therapy?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I89–I95, https://doi.org/10.1093/eurheartjsupp/suac079
Iron deficiency in heart failure: diagnosis and clinical implications
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I96–I99, https://doi.org/10.1093/eurheartjsupp/suac080
Is it possible that angioplasty does not improve the quality of life in patients with stable angina?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I100–I103, https://doi.org/10.1093/eurheartjsupp/suac081
Post-infarct mitral insufficiency: when to resort to reparative surgery, when to the mitral clip
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I104–I110, https://doi.org/10.1093/eurheartjsupp/suac082
Scenarios in precision medicine: proteomics in heart failure
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I111–I113, https://doi.org/10.1093/eurheartjsupp/suac083
Why can primary angioplastics be ineffective despite the precocity of the intervention?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I114–I118, https://doi.org/10.1093/eurheartjsupp/suac102
Is drinking wine in moderation good for health or not?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I119–I122, https://doi.org/10.1093/eurheartjsupp/suac084
Clinical implications of cardiac magnetic resonance imaging fibrosis
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I123–I126, https://doi.org/10.1093/eurheartjsupp/suac085
The risk of acute coronary events in microvascular disease
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I127–I130, https://doi.org/10.1093/eurheartjsupp/suac103
The treatment of amyloidosis is being refined
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I131–I138, https://doi.org/10.1093/eurheartjsupp/suac104
Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I139–I142, https://doi.org/10.1093/eurheartjsupp/suac087
When to set anticoagulant therapy in asymptomatic AF? looking for a cut-off duration
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I143–I147, https://doi.org/10.1093/eurheartjsupp/suac086
The point on the electronic cigarette more than 10 years after its introduction
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I148–I152, https://doi.org/10.1093/eurheartjsupp/suac105
Empagliflozin in heart failure with preserved ejection fraction: first success in mission impossible
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I153–I159, https://doi.org/10.1093/eurheartjsupp/suac106
Cardiology of the future: xenotransplantation with porcine heart
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I160–I164, https://doi.org/10.1093/eurheartjsupp/suac107
When Brugada syndrome is at risk of sudden death: clinical and anatomical aspects
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I165–I169, https://doi.org/10.1093/eurheartjsupp/suac088
Treatment in patients with severe asymptomatic aortic stenosis: is it best not to wait?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I170–I174, https://doi.org/10.1093/eurheartjsupp/suac089
Clinical research methodology process: what has changed with COVID-19?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I175–I180, https://doi.org/10.1093/eurheartjsupp/suac090
Polygenic risk score and age: an extra help in the cardiovascular prevention of the young?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I181–I185, https://doi.org/10.1093/eurheartjsupp/suac091
Association between heart and dementia… keep an eye on the left atrium
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I186–I189, https://doi.org/10.1093/eurheartjsupp/suac092
Cardiac complications of COVID-19 vaccination: now we know more
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I190–I196, https://doi.org/10.1093/eurheartjsupp/suac093
The enigma of resistant hypertension: from lifestyle changes and pharmacological treatment to renal denervation
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I197–I200, https://doi.org/10.1093/eurheartjsupp/suac094
On site cardiac surgery for structural heart interventions: a fence to mend?
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I201–I205, https://doi.org/10.1093/eurheartjsupp/suac108
